Developing and optimizing a decisional instrument using self-reported ancestry for carrier screening in a multi-ethnic society

Genetics in Medicine

Volumn 8, Issue 8, 2006, Pages 502-509

  Lakeman, Phillis ^a   Henneman, Lidewij ^a   Bezemer, Pieter Dirk ^a   Cornel, Martina Cornelia ^a   Kate, Leo Pieter Ten ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ancestry; Cystic fibrosis; Decisional instrument; Hemoglobinopathies; Screening

Indexed keywords

ADULT; ARTICLE; CYSTIC FIBROSIS; DECISION MAKING; ETHNIC DIFFERENCE; FALSE NEGATIVE RESULT; FEMALE; GENETIC SCREENING; GEOGRAPHIC DISTRIBUTION; HEMOGLOBINOPATHY; HUMAN; MALE; NETHERLANDS; OUTCOME ASSESSMENT; QUESTIONNAIRE; SELF REPORT;

ADULT; CYSTIC FIBROSIS; EMIGRATION AND IMMIGRATION; ETHNIC GROUPS; FEMALE; GENETIC SCREENING; HEMOGLOBINOPATHIES; HETEROZYGOTE DETECTION; HUMANS; MALE; NETHERLANDS; QUESTIONNAIRES;

EID: 33747269384     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gim.0000232461.11153.9a     Document Type: Article

References (31)

1. Higgs DR. The thalassemia syndromes. Q J Med 1993;86:559-564.
2. Rosenstein BJ, Zeitlin PL. Cystic fibrosis. Lancet 1998;351:277-282.
3. Welsh MJ, Tsui LC, Boat TF, Beaudet AL. Cystic fibrosis. In, Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The metabolic and molecular basis of inherited disease. New York: McGraw-Hill, 1995;3799-3876.
4. Morris JK, Law MR, Wald NJ. Is cascade testing a sensible method of screening a population for autosomal recessive disorders? Am J Med Genet A 2004;128:271-275.
5. Aspinall PJ, Dyson SM, Anionwu EN. The feasibility of using ethnicity as a primary tool for antenatal selective screening for sickle cell disorders: pointers from the research evidence. Soc Sci Med 2003;56:285-297.
6. Bobadilla JL, Macek M, Jr., Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations- correlation with incidence data and application to screening. Hum Mutat 2002;19:575-606.
7. Edwards QT, Seibert D, Macri C, Covington C, et al. Assessing ethnicity in preconception counseling: genetics-what nurse practitioners need to know. J Am Acad Nurse Pract 2004;16:472-480.
8. Estivill X, Bancells C, Ramos C. Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium. Hum Mutat 1997;10:135-154.
9. Eurogappp. EUROGAPPP PROJECT 1999-2000. Public and Professional Policy Committee (PPPC) Population genetic screening programmes: Proposed recommendations of the European Society of Hum Genet Eur J Hum Genet 2000;8:998-1000.
10. Grody WW, Cutting GR, Klinger KW, Richards CS, et al. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001;3:149-154.
11. Haddow JE, Bradley LA, Palomaki GE, Doherty RA, et al. Issues in implementing prenatal screening for cystic fibrosis: results of a working conference. Genet Med 1999;1:129-135.
12. Kerem E, Kalman YM, Yahav Y, Shoshani T, et al. Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel. Hum Genet 1995;96:193-197.
13. Murray J, Cuckle H, Taylor G, Littlewood J, et al Screening for cystic fibrosis. Health Technol Assess 1999;3:1-104.
14. Angastiniotis M, Modell B. Global epidemiology of hemoglobin disorders. Ann N Y Acad Sci 1998;850:251-269.
15. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ 2001;79:704-712.
16. Gilbert F. Cystic fibrosis carrier screening: steps in the development of a mutation panel. Genet Test 2001;5:223-227.
17. Markel H. The stigma of disease: implications of genetic screening. Am J Med 1992;93:209-215.
18. McQueen MJ. Some ethical and design challenges of screening programs and screening tests. Clin Chim Acta 2002;315:41-48.
19. Bouwhuis CB, Moll HA. Determination of ethnicity in children in The Netherlands: two methods compared. Eur J Epidemiol 2003;18:385-388.
20. Cummins C, Winter H, Cheng KK, Maric R, et al. An assessment of the Nam Pehchan computer program for the identification of names of south Asian ethnic origin. J Public Health Med 1999;21:401-406.
21. Skol AD, Xiao R, Boehnke M. An algorithm to construct genetically similar subsets of families with the use of self-reported ethnicity information. Am J Hum Genet 2005;77:346-354.
22. Weatherall DJ, Letsky EA. Genetic haematological disorders. In, Wald NJ, Leck I (eds): Antenatal and neonatal screening. New York: Oxford University Press, 2000;243-281.
23. Wolters-Noordhoff. Wolters-Noordhoff WERELD@TLAS. 1999. Groningen; The Netherlands, Wolters-Noordhoff Atlas Productions.
24. CBS. Statistics Netherlands. Population statistics, 2006. Voorburg/Heerlen, the Netherlands. Available at: http://www.cbs.nl. Accessed on June 29, 2006.
25. Beighton P, Botha MC. Inherited disorders in the black population of southern Africa. Part I. Historical and demographic background; genetic haematological conditions. S Afr Med J 1986;69:247-249.
26. Bird AR, Ellis P, Wood K, Mathew C, et al Inherited haemoglobin variants in a South African population. J Med Genet 1987;24:215-219.
27. Ahn KM, Park HY, Lee JH, Lee MG, et al. Cystic fibrosis in Korean children:a case report identified by a quantitative pilocarpine iontophoresis sweat test and genetic analysis. J Korean Med Sci 2005;20:153-157.
28. McCormick J, Ogston SA, Sims EJ, Mehta A. Asians with cystic fibrosis in the UK have worse disease outcomes than clinic matched white homozygous delta F508 controls. J Cyst Fibros 2005;4:53-58.
29. Nam MH, Hijikata M, Tuan lA, Lien LT, et al Variations of the CFTR gene in the Hanoi-Vietnamese. Am J Med Genet A 2005;136:249-253.
30. Wu CL, Shu SG, Zielenski J, Chiang CD, et al. Novel cystic fibrosis mutation (2215insG) in two adolescent Taiwanese siblings. J Formos Med Assoc 2000;99:564-567.
31. Condit C, Templeton A, Bates BR, Bevan JL, et al. Attitudinal barriers to delivery of race-targeted pharmacogenomics among informed lay persons. Genet Med 2003;5:385-392.